EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology

UPCOMING EVENTS

    Winter School on Basic Immunology Research in Allergy and Clinical Immunology Hybrid 2022
    27 - 30 January 2022
    Semmering, Austria
    DHM Digital 2022, Drug Hypersensitivity Meeting
    21 April 2022
    Digital
     



Access all our previous articles
& newsletters in PDF format.
On the occasion of World Children's Day on 20 November 2021 and right after our fruitful Pediatric Allergy and Asthma Meeting (PAAM) 2021 we would like to raise awareness together ...
Nominations must be received by January 31, 2022The objective of PhARF (Phadia Allergy Research Forum) is to encourage progress in allergy research, specifically through the PhARF ...
Over 1500 abstracts from the last EAACI Hybrid Congress 2021, held in Krakow, Poland and digitally are now published and available for consultation in a special issue of EAACI’s ...
As per the Executive Committee meeting held 09 July 2021, a new Working Group Epithelial Cell Biology was approved per majority vote. The new Working Group Epithelial Cell Biology...
EAACI is seeking experienced individuals for the positions of Knowledge Hub Editor-in-Chief and Deputy Editor, to be part of an important team dedicated to the growth of the Academ...
We have the honour and pleasure to invite our colleagues to contribute to the scientific programme of the EAACI Hybrid Congress 2022 to be held in Prague, Czech Republic, ...
On this World Food Day 2021, EAACI wants to raise awareness of the burden of food allergy and the importance of creating solid plans for its prevention, diagnosis and care. Mo...
We are glad to announce that the EAACI Pediatric Allergy and Asthma Meeting (PAAM Digital 2021) has been granted 16 European CME credits (ECMEC®s) by the European Accreditation Co...
Next
We would like to warmly invite you to register for the upcoming one-day Meeting of the AllergoOncology Working Group “Danger Signals, Inflammation in Allergy and Cancer” whic...
EAACI and Allergopharma are pleased to announce the opening of applications for the EAACI – Allergopharma Research Award 2022.Apply now until November 17, 2021.The award recognis...
EAACI is pleased to announce the opening of the application period for the EAACI Research and Clinical Fellowships 2022.Applications are open until November 17, 2021. The EAACI Res...
We invite you to read the ERS/EAACI statement on Adherence to International Adult Asthma Guidelines, taken from the ERS Congress pre-event programme. This presentation recites the ...
EAACI supports medical professionals from the beginning of their studies and throughout their professional careers. Here you can find a selection of job opportunities.Consulta...
We are proud to announce the launch of the new EAACI Guidelines on Omalizumab for the treatment of Chronic Spontaneous Urticaria, a major scientific output of 2021 for the Academy....
In 2019, the EAACI Working Group on Primary Care invited EAACI members to work with us to identify the needs of European general medical practitioners (GPs) with regards to allergi...
Rational use of antibiotics has become an essential topic in clinical care, mainly because of emerging antimicrobial resistance which is a threat to global health. Patients with al...
Previous
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel